CCI gives green signal for Nirma’s acquisition in Glenmark Life Sciences

20 Dec 2023 Evaluate

The Competition Commission of India (CCI) has given approval for Nirma’s acquisition of majority shareholding in Glenmark Life Sciences. In September this year, Glenmark Pharmaceuticals’ board had approved to divest 75 per cent stake in its subsidiary Glenmark Life Sciences to Nirma for Rs 5,651.5 crore.

Ahmedabad-based Nirma is known for its detergents, soap, and dishwashing bars. It is also into the manufacturing of industrial products like soda ash, linear alkyl benzene, alfa olefin sulphonates, fatty acid, glycerine, and sulphuric acid. 

Glenmark Life Sciences is in the business of making high-quality drugs by unlocking the possibilities of science.


Alivus Life Sciences Share Price

907.55 -9.70 (-1.06%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×